These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

587 related articles for article (PubMed ID: 33070079)

  • 21. Risk management strategies and therapeutic modalities to tackle COVID-19/SARS-CoV-2.
    Shah SMA; Rasheed T; Rizwan K; Bilal M; Iqbal HMN; Rasool N; Toma S; Marceanu LG; Bobescu E
    J Infect Public Health; 2021 Mar; 14(3):331-346. PubMed ID: 33618278
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An update on emerging therapeutics to combat COVID-19.
    Shah NN; Nabi SU; Rather MA; Kalwar Q; Ali SI; Sheikh WM; Ganai A; Bashir SM
    Basic Clin Pharmacol Toxicol; 2021 Aug; 129(2):104-129. PubMed ID: 33977663
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A critical overview of current progress for COVID-19: development of vaccines, antiviral drugs, and therapeutic antibodies.
    Kumari M; Lu RM; Li MC; Huang JL; Hsu FF; Ko SH; Ke FY; Su SC; Liang KH; Yuan JP; Chiang HL; Sun CP; Lee IJ; Li WS; Hsieh HP; Tao MH; Wu HC
    J Biomed Sci; 2022 Sep; 29(1):68. PubMed ID: 36096815
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular Insights of SARS-CoV-2 Infection and Molecular Treatments.
    Abdurrahman L; Fang X; Zhang Y
    Curr Mol Med; 2022; 22(7):621-639. PubMed ID: 34645374
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potential approaches to combat COVID-19: a mini-review.
    Sarwar Z; Ahmad T; Kakar S
    Mol Biol Rep; 2020 Dec; 47(12):9939-9949. PubMed ID: 33185828
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Beyond Vaccines: Clinical Status of Prospective COVID-19 Therapeutics.
    Kumar S; Çalışkan DM; Janowski J; Faist A; Conrad BCG; Lange J; Ludwig S; Brunotte L
    Front Immunol; 2021; 12():752227. PubMed ID: 34659259
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Guide to COVID-19: a global pandemic caused by the novel coronavirus SARS-CoV-2.
    Atzrodt CL; Maknojia I; McCarthy RDP; Oldfield TM; Po J; Ta KTL; Stepp HE; Clements TP
    FEBS J; 2020 Sep; 287(17):3633-3650. PubMed ID: 32446285
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Era of the Coronavirus Disease 2019 Pandemic: A Review on Dynamics, Clinical Symptoms and Complications, Diagnosis, and Treatment.
    Younis NK; Zareef RO; Maktabi MAN; Mahfouz R
    Genet Test Mol Biomarkers; 2021 Feb; 25(2):85-101. PubMed ID: 33596144
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An update on COVID-19: SARS-CoV-2 life cycle, immunopathology, and BCG vaccination.
    Khade SM; Yabaji SM; Srivastava J
    Prep Biochem Biotechnol; 2021; 51(7):650-658. PubMed ID: 33226885
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The 2020 race towards SARS-CoV-2 specific vaccines.
    Karpiński TM; Ożarowski M; Seremak-Mrozikiewicz A; Wolski H; Wlodkowic D
    Theranostics; 2021; 11(4):1690-1702. PubMed ID: 33408775
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug repurposing approach to combating coronavirus: Potential drugs and drug targets.
    Xu J; Xue Y; Zhou R; Shi PY; Li H; Zhou J
    Med Res Rev; 2021 May; 41(3):1375-1426. PubMed ID: 33277927
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SARS-CoV-2: Immune Response Elicited by Infection and Development of Vaccines and Treatments.
    Canedo-Marroquín G; Saavedra F; Andrade CA; Berrios RV; Rodríguez-Guilarte L; Opazo MC; Riedel CA; Kalergis AM
    Front Immunol; 2020; 11():569760. PubMed ID: 33362758
    [TBL] [Abstract][Full Text] [Related]  

  • 33. COVID-19: Unmasking Emerging SARS-CoV-2 Variants, Vaccines and Therapeutic Strategies.
    Raman R; Patel KJ; Ranjan K
    Biomolecules; 2021 Jul; 11(7):. PubMed ID: 34356617
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In-line treatments and clinical initiatives to fight against COVID-19 outbreak.
    Agrawal M; Saraf S; Saraf S; Murty US; Kurundkar SB; Roy D; Joshi P; Sable D; Choudhary YK; Kesharwani P; Alexander A
    Respir Med; 2022 Jan; 191():106192. PubMed ID: 33199136
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel Coronavirus: A Review from Origin to Current Status of Therapeutic Strategies.
    Hassan M; Zalkifal M; Wahab A; Afzal S; Rafique S; Shahid M; Khan MA; Ahmed N; Idrees M; Shahid AA
    Crit Rev Eukaryot Gene Expr; 2021; 31(3):21-34. PubMed ID: 34369712
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The growing complexity of COVID-19 drug and vaccine candidates: challenges and critical transitions.
    Shariare MH; Parvez MAK; Karikas GA; Kazi M
    J Infect Public Health; 2021 Feb; 14(2):214-220. PubMed ID: 33493917
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
    Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G
    J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potential drug development and therapeutic approaches for clinical intervention in COVID-19.
    Dowarah J; Marak BN; Yadav UCS; Singh VP
    Bioorg Chem; 2021 Sep; 114():105016. PubMed ID: 34144277
    [TBL] [Abstract][Full Text] [Related]  

  • 39. COVID-19: Transmission, prevention, and potential therapeutic opportunities.
    Lotfi M; Hamblin MR; Rezaei N
    Clin Chim Acta; 2020 Sep; 508():254-266. PubMed ID: 32474009
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Therapeutic Journey of Potential Drugs Against COVID-19.
    Ali F; Hussain S; Zhu YZ
    Mini Rev Med Chem; 2022; 22(14):1876-1894. PubMed ID: 33845740
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.